Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription

H Shimura1, H Suzuki, A Miyazaki

  • 1Third Department of Internal Medicine, Yamanashi Medical University, Yamanashi 409-3898, Japan.

Cancer Research
|April 28, 2001
PubMed

Insights

Gene therapy using TTF-1 gene transfer and a suicide gene effectively targets thyroid cancer cells that don't produce thyroglobulin. This approach shows significant cytotoxicity in poorly differentiated thyroid carcinomas, offering a new treatment strategy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Therapy

Background:

  • Thyroid carcinoma treatment faces challenges with poorly differentiated and anaplastic types that lose thyroglobulin (TG) gene expression.
  • Loss of TG expression is linked to reduced activity of key transcription factors like thyroid transcription factor-1 (TTF-1), TTF-2, and Pax-8.
  • Targeting TG-nonproducing thyroid carcinomas requires strategies that overcome the lack of endogenous TG promoter activity.

Purpose of the Study:

  • To investigate the effect of TTF-1 gene transfer on TG promoter activity in thyroid cancer cells.
  • To evaluate the cytotoxic efficacy of a TG promoter-driven suicide gene (HSV-TK) combined with ganciclovir (GCV) in various cell lines.
  • To develop a transcriptionally targeted gene therapy for TG-nonproducing thyroid carcinomas.

Main Methods:

  • Utilized a luciferase reporter assay with a rat TG gene 5'-flanking region construct to assess promoter activity.
  • Employed recombinant adenovirus vectors: AdTTF-1 (for TTF-1 expression) and AdTGTK (for TG promoter-driven HSV-TK).
  • Assessed cytotoxicity through combined AdTTF-1 and AdTGTK cotransduction followed by ganciclovir treatment in differentiated, dedifferentiated, and nonthyroidal cell lines.

Main Results:

  • TTF-1 gene transfer significantly stimulated TG promoter activity in dedifferentiated thyroid cells (FRT, BHP15-3) lacking endogenous TTF-1.
  • Adenovirus-mediated TG promoter-driven HSV-TK and ganciclovir treatment showed cytotoxicity in normal thyroid cells (FRTL-5) but not in dedifferentiated or nonthyroidal cells.
  • Cotransduction of AdTTF-1 and AdTGTK resulted in high cytotoxicity (>90%) in multiple TG-nonproducing thyroid cancer cell lines, with minimal effect on non-target cells.

Conclusions:

  • Restoring TTF-1 expression can reactivate the TG promoter in dedifferentiated thyroid cancer cells.
  • Adenoviral cotransduction of TTF-1 and a TG promoter-controlled suicide gene provides a transcriptionally targeted approach for gene therapy.
  • This strategy demonstrates significant potential for selectively eliminating poorly differentiated thyroid carcinoma cells that lack TG gene expression.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...